株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の体外診断薬 (IVD) 市場の分析

Global In-Vitro Diagnostics (IVD) Market 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 425930
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
世界の体外診断薬 (IVD) 市場の分析 Global In-Vitro Diagnostics (IVD) Market 2019-2025
出版日: 2019年12月20日 ページ情報: 英文
概要

当レポートでは、世界の体外診断薬 (IVD) 市場について調査分析し、市場影響要因、地域別の規制・政策、市場決定要因、収益予測、主要企業のプロファイルや最近の動向など、体系的な情報を提供しています。

第1章 レポートサマリー

第2章 市場概要と考察

  • 定義
  • ギャップ分析
  • 歴史的分析
  • 現在の市場動向
  • アナリストの考察
  • 規制

第3章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第4章 市場分析

第5章 市場区分

  • 用途別
  • 種類別
  • エンドユーザー別
  • 有用性別
  • 技術別

第6章 競合情勢

  • 主要戦略分析
  • 主要企業分析

第7章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第8章 企業プロファイル

  • ABBOTT LABORATORIES, INC.
  • ALERE INC
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX
  • BIO-RAD LABORATORIES, INC.
  • DANAHER CORPORATION
  • ELITECH GROUP
  • JOHNSON & JOHNSON
  • KEM-EN-TEC DIAGNOSTICS INC
  • MEDTRONIC
  • OMEGA DIAGNOSTICS GROUP
  • ORTHO CLINICAL DIAGNOSTICS, INC.
  • ROCHE DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • TRANSASIA BIO-MEDICALS
  • WERFEN GROUP
図表

List of Tables

1. GLOBAL IVD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

2. GLOBAL IVD FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL IVD FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL IVD FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL IVD FOR DRUG TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL IVD FOR AUTOIMMUNE DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL IVD FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL IVD MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

9. GLOBAL IVD INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL IVD REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

11. GLOBAL IVD SOFTWARE AND SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL IVD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

13. GLOBAL IMMUNODIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

14. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

15. GLOBAL HEMATOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

16. GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

17. GLOBAL OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

18. GLOBAL IVD MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

19. GLOBAL IVD IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

20. GLOBAL IVD IN DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

21. GLOBAL IVD IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

22. GLOBAL IVD MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

23. NORTH AMERICAN IVD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

24. NORTH AMERICAN IVD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

25. NORTH AMERICAN IVD MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

26. NORTH AMERICAN IVD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

27. NORTH AMERICAN IVD MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

28. EUROPEAN IVD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

29. EUROPEAN IVD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

30. EUROPEAN IVD MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

31. EUROPEAN IVD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

32. EUROPEAN IVD MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

33. ASIA-PACIFIC IVD MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

34. ASIA-PACIFIC IVD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

35. ASIA-PACIFIC IVD MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

36. ASIA-PACIFIC IVD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

37. ASIA-PACIFIC IVD MARKET RESEARCH AND ANALYSIS BY END-USER 2018-2025 ($ MILLION)

38. REST OF THE WORLD IVD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

39. REST OF THE WORLD IVD MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

40. REST OF THE WORLD IVD MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

41. REST OF THE WORLD IVD MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

List of Figures

1. GLOBAL IVD MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

2. GLOBAL IVD MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

3. GLOBAL IVD MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)

4. GLOBAL IVD MARKET SHARE BY END-USER, 2018 VS 2025 (%)

5. GLOBAL IVD MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

6. US IVD SIZE, 2018-2025 ($ MILLION)

7. CANADA IVD MARKET SIZE, 2018-2025 ($ MILLION)

8. UK IVD MARKET SIZE, 2018-2025 ($ MILLION)

9. FRANCE IVD MARKET SIZE, 2018-2025 ($ MILLION)

10. GERMANY IVD MARKET SIZE, 2018-2025 ($ MILLION)

11. ITALY IVD MARKET SIZE, 2018-2025 ($ MILLION)

12. SPAIN IVD MARKET SIZE, 2018-2025 ($ MILLION)

13. ROE IVD MARKET SIZE, 2018-2025 ($ MILLION)

14. INDIA IVD MARKET SIZE, 2018-2025 ($ MILLION)

15. CHINA IVD MARKET SIZE, 2018-2025 ($ MILLION)

16. JAPAN IVD MARKET SIZE, 2018-2025 ($ MILLION)

17. REST OF ASIA-PACIFIC IVD MARKET SIZE, 2018-2025 ($ MILLION)

18. REST OF THE WORLD IVD MARKET SIZE, 2018-2025 ($ MILLION)

目次
Product Code: OMR2020053

In-Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report, By Application (Diabetes, Infectious Diseases, Cancer, Drug Testing, Autoimmune Diseases and Others), By Product (Instruments, Reagents and Software and Services), By Technology (Immunodiagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics and Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories and Others) and Forecast, 2019-2025

The global in-vitro diagnostics (IVD) market is estimated to grow at a CAGR of X% during the forecast period. The major factors contributing to the growth of the market include a significant rise in the prevalence of chronic and infectious diseases, growing technological advances in IVD testing tools and the rising adoption of non-invasive diagnostic tests. The advent of next-generation sequencing (NGS) has created a significant opportunity for advances in IVD tests.

There are three types of NGS technologies which include first-generation (sanger sequencing), high-throughput sequencing and third-generation sequencing. Sanger sequencing can be an ideal option while examining a small section of DNA on a smaller number of genomic targets or samples (approximately 20 or fewer). Whereas, high-throughput sequencing holds the ability to screen more samples effectively and enables the sequencing of millions of fragments in a single run. Hence, it is primarily being adopted in key research projects, such as MetaHIT and Human Microbiome Project.

The companies are using advanced NGS technologies to provide diagnostic solutions targeting liver diseases. In January 2019, GENFIT SA signed a licensing agreement with LabCorp to expand access to NIS4, a non-invasive IVD assay which is created specifically for NASH (Non-Alcoholic Steatohepatitis). This licensing agreement is aimed at expanding access to NIS4 in the global research community. GENFIT uses NGS that enables to perform sequencing of millions of small DNA fragments in parallel. Moreover, NGS technologies are currently used in clinical research laboratories to develop tests that can provide meaningful genetic information for multiple human conditions. Therefore, NGS-based IVD testing can support to increase the reliability and accuracy of IVD, which thereby will contribute to the growth of the market.

North America is anticipated to hold the major share in the market in 2018 owing to well-developed healthcare infrastructure and significant funding opportunities for medical research institutions and biopharmaceutical firms. However, Asia-Pacific is estimated to witness lucrative growth in the market owing to the emerging adoption of molecular diagnostics in the region. Moreover, improving hospital infrastructure and rising diagnostic centers have been led to the installation of automated and semi-automated biochemistry, immunology, and hematology equipment in the region.

Some crucial players in the market include Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH and QIAGEN GmbH. IVD companies are constantly focusing on R&D, partnerships, product launches and mergers and acquisitions to gain a competitive advantage over their competitors . For instance, in April 2018, altona Diagnostics GmbH declared the launch of AltoStar molecular diagnostic workflow. The benefits include process reliability, time and cost efficiency and high flexibility of operation and handling were important targets for the development of this new system.

Research Methodology

The market study of the global IVD market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for IVD tools manufacturers, suppliers and distributors, government agencies and research institutions for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global IVD Market Research and Analysis, By Application
  • Global IVD Market Research and Analysis, By Product
  • Global IVD Market Research and Analysis, By Technology
  • Global IVD Market Research and Analysis, By End-User

The Report covers:

  • Comprehensive research methodology of the global IVD market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global IVD market.
  • Insights about market determinants which are stimulating the global IVD market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Thermo Fisher Scientific, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Abbott Laboratories, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. F. Hoffmann-La Roche Ltd.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Siemens Healthcare GmbH
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. QIAGEN GmbH
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global IVD Market by Application
    • 5.1.1. Diabetes
    • 5.1.2. Infectious Diseases
    • 5.1.3. Cancer
    • 5.1.4. Drug Testing
    • 5.1.5. Autoimmune Diseases
    • 5.1.6. Others (Nephrology and Cardiology)
  • 5.2. Global IVD Market by Product
    • 5.2.1. Instruments
    • 5.2.2. Reagents
    • 5.2.3. Software and Services
  • 5.3. Global IVD Market by Technology
    • 5.3.1. Immunodiagnostics
    • 5.3.2. Molecular Diagnostics
    • 5.3.3. Hematology
    • 5.3.4. Tissue Diagnostics
    • 5.3.5. Others (Clinical Chemistry and Coagulation)
  • 5.4. Global IVD Market by End-User
    • 5.4.1. Hospitals & Clinics
    • 5.4.2. Diagnostic Laboratories
    • 5.4.3. Others (Academics and Research Institutions)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Alere, Inc.
  • 7.3. Atlas genetics Ltd.
  • 7.4. Becton, Dickinson & Co.
  • 7.5. bioMerieux, Inc.
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. Danaher Corp.
  • 7.8. ELITechGroup
  • 7.9. F. Hoffmann-La Roche Ltd.
  • 7.10. Illumina, Inc.
  • 7.11. Kem-En-Tec Diagnostics A/S
  • 7.12. Luminex Corp.
  • 7.13. Omega Diagnostics Ltd.
  • 7.14. Ortho Clinical Diagnostics, Inc.
  • 7.15. QIAGEN GmbH
  • 7.16. Siemens Healthcare GmbH
  • 7.17. Sysmex Corp.
  • 7.18. Thermo Fisher Scientific, Inc.
  • 7.19. Transasia Bio-Medicals Ltd.
  • 7.20. WerfenLife, S.A.
Back to Top